Member Info for Timster

nailed on, whoop whoop

https://www.worldometers.info/coronavirus/

55 million cases

Its not going the market is enormous! there are 197 countries on that list (excluding those with less than 100 cases)

The logistics of vaccinating all those countries is massive. What do they need to help bring down the R number in the meantime?

It confirms nothing has failed or stopped. Progress is being made.

May not be quick enough for the armchair scientists but for those actual scientists creating new innovative tech its a reality and happening (and yes even they have been frustrated by how long CONDOR has taken over BAMS).

From 7 days ago on twitter:
An informative and measured commentary from
@finnCap
on yesterday’s vaccine news:
https://researchlibrary.finncap.com/File/View?file=15ad8f12-f9f3-4694-b5bf-915b66972cc6 #AVCT 1/6

As
@finnCap
note in their commentary, and others have said, the testing market will be around for years and is so large that demand will out-strip supply even of multiple tests. #AVCT 2/6

Effective roll-out of vaccines, if successfully developed, will still take a significant amount of time and, sadly, will take even longer in the developing world. #AVCT 3/6Effective roll-out of vaccines, if successfully developed, will still take a significant amount of time and, sadly, will take even longer in the developing world. #AVCT 3/6

We continue to make very good progress with a rapid antigen test and with the laboratory based mass spectrometry test. We are preparing for the first clinical evaluation of the rapid antigen test and will update the market fully when that study begins. #AVCT 4/6

We are conducting a clinical evaluation of the BAMS assay at several sites in the UK and will update the market shortly when we have those data. We continue to make significant commercial progress for these tests, and the SARS-CoV-2 spike protein research ELISA. #AVCT 5/6

We are also on track to make the regulatory submission for the first of Avacta’s revolutionary tumour activated chemotherapies, AVA600 pro-doxorubicin, in 2020 and dose first patients in the UK in early 2021. #AVCT 6/6

LOLZ ROFL

Still 32 working days of Q4 left

great bit of twittering by BBN

He legally has to richar. So I don't thing we need to worry

that's very interesting, I'd forgotten we licensed Moderna for Affimer usage

absolute **** take done it across all covid related stocks again!!

how ridiculous I cant spell ridiculous

How ridiculos are these drops!! we know vaccines wont be available to make a difference until next winter and we also know testing will be required for years and years...

nice shake this morning weed out the nervous and then back to normal...

https://twitter.com/drlennardlee/status/1327684060546789376?s=09

Sorry yep presentation end of Sep, doesn't time fly....

Pointless!! As per all the is it us posts.
We know from recent tweets all is going well. Only time we will know for sure what's going on is when an RNS lands to confirm one of the following.
1. BAMS Validated
2. LFT pilot batch produced after tech transfer and clinical evaluation begins
3. AVA6000 trial submitted

Until then there really has been no change since the investor webcast end of October.

Hoping next week will bring us investors some real clarity and we start to see some value inflection points we've been told about. GLA

It's going to be us at some point and Q4 with any luck....

I'm very surprised the media hasn't exposed it at Chinese ****e sold from a one man ltd companies garage!

The incredible detectives on this board didn't take long to uncover that so why haven't the investigative journos

It's next week for sure! Is it us? Course it is!!!

good use of "inflection point" too as per Avacta SP inflection points incoming......